Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing HL301 to placebo in acute bronchitis has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• HL301

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Acute Bronchitis | Phase 2 | Status: COMPLETED